1-3 of 3
Semira Sheikh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CO43923: A Platform Study Evaluating the Safety and Efficacy of Multiple Treatment Combinations in Patients with Multiple Myeloma

Semira Sheikh, Upen Patil, Kristin Wehrman, Elissavet Sideri, Shannon M. Ruppert, Yanke Yu, Mark Yan, Jasdeep Bhatti, Lydia Pogeza, Yann Nouet
Journal: Blood
Blood (2022) 140 (Supplement 1): 12640–12641.
https://doi.org/10.1182/blood-2022-157737
Published: 2022
Journal Articles

The TLR Adaptor Protein MyD88 Mediates Cell Sensitivity to HDAC Inhibitors through a Cytokine-Dependent Mechanism

Semira Sheikh, MDBSc,FRCPath, Maria New, PhD, Mina Bekheet, Heidi Olzscha, PhD, Nicholas B La Thangue, PhD FRSE FMedSci
Journal: Blood
Blood (2016) 128 (22): 1766.
https://doi.org/10.1182/blood.V128.22.1766.1766
Published: 2016
Journal Articles

Results of a Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CXD101: Preliminary Safety and Activity in Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma Patients

Toby A. Eyre, MD, Graham P. Collins, MD PhD, Avinash Gupta, Semira Sheikh, MD BSc,FRCPath, Victoria Woodcock, MD, John Whittaker, Lai Mun Wang, Elizabeth Soilleux, Finn Tysoe, Richard Cousins, Nick La Thangue, David Kerr, Mark R. Middleton, PhD
Journal: Blood
Blood (2016) 128 (22): 1817.
https://doi.org/10.1182/blood.V128.22.1817.1817
Published: 2016